1,160 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Will American Airlines (AAL) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204196/will-american-airlines-aal-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204196 Jan 01, 2024 - American Airlines (AAL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Comcast (CMCSA) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204197/will-comcast-cmcsa-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204197 Jan 01, 2024 - Comcast (CMCSA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Paccar (PCAR) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204194/will-paccar-pcar-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204194 Jan 01, 2024 - Paccar (PCAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204200/will-unitedhealth-unh-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204200 Jan 01, 2024 - UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Valero Energy (VLO) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204199/will-valero-energy-vlo-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204199 Jan 01, 2024 - Valero Energy (VLO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Caterpillar (CAT) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204201/will-caterpillar-cat-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204201 Jan 01, 2024 - Caterpillar (CAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Verizon (VZ) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2204202/will-verizon-vz-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204202 Jan 01, 2024 - Verizon (VZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Accolade (ACCD) Report Negative Earnings Next Week? What You Should Know https://www.zacks.com/stock/news/2204172/will-accolade-accd-report-negative-earnings-next-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2204172 Jan 01, 2024 - Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Friday's Selloff Can Extend Next Week, You Should Buy https://seekingalpha.com/article/4660564-friday-selloff-can-extend-next-week-you-should-buy?source=feed_all_articles Dec 31, 2023 - The stock market's unexpected sell-off sparks curiosity. Check out the factors that could impact the market to the downside in Q1 2024.
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics https://www.fool.com/investing/2023/12/31/gene-editing-stocks-that-might-be-the-next-crispr/?source=iedfolrf0000001 Dec 31, 2023 - Curing rare inherited illnesses could be a lucrative business model.
<<<Page 108>